eIF4E was found to inhibit aldehyde dehydrogenase (ALDH) activity and increase the ferroptosis sensitivity of ovarian cancer cells by accumulating lethal lipid peroxidation[82,83]. Here, EIF4E is linked to ovarian carcinoma.